The Medicines (Products for Human Use) (Fees) Regulations 2016: what changed
238 changes of wording, as read on 20 Nov 2026.
The latest 200 of 238.
2
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 20 · Fees for modifications to clinical trial authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 49 · Clinical trial authorisations
69
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, 3a · Fee for scientific or other advice
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 4 · Fee for scientific advice: application for, or variation to, EU marketing authorisation
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 5 · Fee for scientific advice: classification of a medicinal product
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 6 · Fee for advertising advice
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 7 · Fee for pharmacovigilance advice
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 8 · Fee for advice on labelling or leaflets
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 9 · Fee for regulatory advice
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 10 · Fee for advice for other purposes
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 10a · Waiver for advice given to small and medium companies
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 11 · Time for payment of fees under regulations 3A to 8
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 14 · Fee for applications for additional copy certificates
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 15 · Fees for applications for certificates and copy certificates by exporters of medicinal products
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 19a · Fees for certification of plasma master files
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 19b · Fee for certification of vaccine antigen master files
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 19c · Fees for assessment of post-authorisation safety studies
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 19e · Fee for assessment of periodic safety update reports
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 19ea · Fee for assessment of clinical trial annual safety reports
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 21 · Fees for notification of changes and reports for broker's registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 22 · Fees for notification of changes and compliance Reports for active substance registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 27 · Fees for renewals of certain manufacturer's licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 41 · Fees for applications for membership and certificates
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 42 · Fee for a review upon oral representations or a person appointed hearing
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 44 · Interpretation
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 47 · Fees for variations of certificates
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 21 · Standard variation application for a homoeopathic medicinal product
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 24 · Marketing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 25 · Fees where application includes reclassification
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 28 · Application for multiple authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 28a · Application by pre-assessment of modules
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 29 · Authorisation for a national homoeopathic product
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 30 · Manufacturer's licences and authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 31 · Wholesale dealer's licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 33 · Active substance registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 34 · Clinical trial authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 35 · Traditional herbal registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 35a · Early Access to Medicines Scheme fees
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 38 · Marketing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 40 · Reclassification of marketing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 41 · Variation of marketing authorisation: national homoeopathic products
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 42 · Variation of parallel import licence
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 43 · Manufacturer's authorisations and licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 44 · Variation of manufacturer's authorisations and licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 45 · Wholesale dealer's licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 46 · Variation of wholesale dealer's licence
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 47 · Variation of a broker's registration
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 48 · Variation of an active substance registration
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 49 · Clinical trial authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 50 · Traditional herbal registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 54 · A set of changes
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 56 · Renewal of a marketing authorisation
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 57 · Renewal of multiple marketing authorisations
- amended
- amended
- amended
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 5 · Wholesale dealer's licence: general
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 6 · Wholesale dealer's licence: traditional herbal medicinal products
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 7 · Wholesale dealer's licences: inspection of short duration
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 8 · Broker's registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 9 · Active substance registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 10 · Office-based inspections
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 5 · Marketing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 6 · Marketing authorisation: where Part 2 of the Act applies
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 7 · Marketing authorisation: derivatives
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 11 · Manufacturer's licences or manufacturing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 12 · Wholesale dealer's licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 15 · Additional amount for manufacturer's licences and wholesale dealer's licences which relate to special medicinal products
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 16 · Traditional herbal registrations
- amended
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 7, para. 11 · Scientific advice: paediatric indications
64
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 4 · Fee for scientific advice: application for, or variation to, EU marketing authorisation
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 5 · Fee for scientific advice: classification of a medicinal product
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 6 · Fee for advertising advice
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 7 · Fee for pharmacovigilance advice
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 8 · Fee for advice on labelling or leaflets
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 9 · Fee for regulatory advice
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 10 · Fee for advice for other purposes
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 12 · Fees for applications for authorisations, registrations, licences or certificates etc.
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 14 · Fee for applications for additional copy certificates
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 15 · Fees for applications for certificates and copy certificates by exporters of medicinal products
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 19a · Fees for certification of plasma master files
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 19b · Fee for certification of vaccine antigen master files
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 19c · Fees for assessment of post-authorisation safety studies
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 19e · Fee for assessment of periodic safety update reports
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, 19ea · Fee for assessment of clinical trial annual safety reports
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 21 · Fees for notification of changes and reports for broker's registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 22 · Fees for notification of changes and compliance Reports for active substance registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 27 · Fees for renewals of certain manufacturer's licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 41 · Fees for applications for membership and certificates
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 42 · Fee for a review upon oral representations or a person appointed hearing
- amended
- amended
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 24 · Marketing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 25 · Fees where application includes reclassification
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 27 · Joint development
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 28 · Application for multiple authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 28a · Application by pre-assessment of modules
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 30 · Manufacturer's licences and authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 31 · Wholesale dealer's licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 32 · Broker's registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 33 · Active substance registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 34 · Clinical trial authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 35 · Traditional herbal registrations
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 35a · Early Access to Medicines Scheme fees
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 38 · Marketing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 40 · Reclassification of marketing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 42 · Variation of parallel import licence
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 43 · Manufacturer's authorisations and licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 44 · Variation of manufacturer's authorisations and licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 45 · Wholesale dealer's licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 46 · Variation of wholesale dealer's licence
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 47 · Variation of a broker's registration
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 48 · Variation of an active substance registration
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 49 · Clinical trial authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 53 · Multiple reclassification variation applications
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 54 · A set of changes
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 56 · Renewal of a marketing authorisation
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 57 · Renewal of multiple marketing authorisations
- amended
- amended
- amended
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 5 · Wholesale dealer's licence: general
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 6 · Wholesale dealer's licence: traditional herbal medicinal products
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 7 · Wholesale dealer's licences: inspection of short duration
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 8 · Broker's registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 9 · Active substance registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 3, para. 10 · Office-based inspections
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 5 · Marketing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 6 · Marketing authorisation: where Part 2 of the Act applies
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 7 · Marketing authorisation: derivatives
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 11 · Manufacturer's licences or manufacturing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 12 · Wholesale dealer's licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 15 · Additional amount for manufacturer's licences and wholesale dealer's licences which relate to special medicinal products
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 4, para. 16 · Traditional herbal registrations
1
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 10 · Fee for advice for other purposes
35
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, 10a · Waiver for advice given to small and medium companies
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 19 · Fees for variations of authorisations, registrations and licences
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, 19a · Fees for certification of plasma master files
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, 19b · Fee for certification of vaccine antigen master files
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, 19c · Fees for assessment of post-authorisation safety studies
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, 19d · Fee for carrying out a major safety review
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, 19e · Fee for assessment of periodic safety update reports
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, 19f · Fee for testing of samples by the appropriate authority
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, 19g · Time for payment of fees under regulations 19A to 19F
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 23 · Applications for multiple variations
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, 27a · Fee for renewals of a marketing authorisation
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 29 · Fees for regulatory assistance for certain marketing authorisations
- amended
- new
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 4 · Extension application
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 22 · Type IB and Type II Applications
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 23 · Type II Complex Variation Application
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 24 · Marketing authorisations
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 24a · Fees where an application for a European Union marketing authorisation had been made before IP completion day
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 27 · Joint development
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 28 · Application for multiple authorisations
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 28a · Application by pre-assessment of modules
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 38 · Marketing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 39 · Variation of marketing authorisations
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 39a · Variation of orphan marketing authorisations: small and medium companies
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 40a · Fees where an application for a variation or an extension of a European Union marketing authorisation had been made before IP completion day
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 56 · Renewal of a marketing authorisation
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 57 · Renewal of multiple marketing authorisations
- new
- new
- amended
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 6, para. 2 · Major application
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 7, para. 7a · Orphan marketing authorisation
- amended
- new
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 8, para. 2a · Waiver or refund: converted EU marketing authorisations
1
- amended
28
- amended
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 6 · Fee for advertising advice
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 10 · Fee for advice for other purposes
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 12 · Fees for applications for authorisations, registrations, licences or certificates etc.
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 15 · Fees for applications for certificates and copy certificates by exporters of medicinal products
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 19 · Fees for variations of authorisations, registrations and licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 21 · Fees for notification of changes and reports for broker's registrations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 23 · Applications for multiple variations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 27 · Fees for renewals of certain manufacturer's licences
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 28 · Fees for renewals in terms which are not identical to the existing authorisation, licence or registration
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 29 · Fees for regulatory assistance for certain marketing authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 30 · Fees for inspections
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 33 · Inspections in connection with multiple applications
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 35 · Amount, and time for payment, of inspection fees in respect of an application for a wholesale dealer's licence
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 36 · Adjustment and refund of inspection fees in respect of a wholesale dealer's licence
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 37 · Amount, and time for payment, of inspection fees in respect of an application for a broker's registration or an active substance registration
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 38 · Periodic fees
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 42 · Fee for a review upon oral representations or a person appointed hearing
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 50 · Time for payment of capital fees in connection with applications or inspections
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 51 · Time for payment of capital fees – applications made by small companies
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 58 · Suspension of licences and authorisations
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 60 · Amendment of the Medical Devices (Consultation Requirements) (Fees) Regulations 1995
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 61 · Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, 62 · Amendment of the Human Medicines Regulations 2012
- amended
- amended
- amended
- amended
Medicines (Products for Human Use) (Fees) Regulations 2016, Sch. 2, para. 7 · Complex variation application